histidine has been researched along with Choroid Neovascularization in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, S; Capone, A; DeAngelis, MM; Dryja, TP; Ji, F; Kim, IK; Lane, AM; Miller, JW; Morrison, MA; Ott, J; Zhang, Q | 1 |
| Averbukh, E; Axer-Siegel, R; Banin, E; Chowers, I; Cohen, Y; Goldenberg-Cohen, N; Hemo, I; Lederman, M; Lichtinger, A; Meir, T; Pollack, A; Vicuna-Kojchen, J; Weinstein, O | 1 |
2 other study(ies) available for histidine and Choroid Neovascularization
| Article | Year |
|---|---|
Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration.
Topics: 3' Untranslated Regions; Aged; Aged, 80 and over; C-Reactive Protein; Choroidal Neovascularization; Complement Factor H; Demography; Environment; Exons; Gene Frequency; Haplotypes; Histidine; Humans; Linkage Disequilibrium; Macular Degeneration; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Regression Analysis; Risk Factors; Tyrosine | 2008 |
Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel.
Topics: Aged; Choroidal Neovascularization; Complement Factor H; Female; Gene Frequency; Genetic Predisposition to Disease; Histidine; Humans; Israel; Macular Degeneration; Male; Phenotype; Photochemotherapy; Polymorphism, Single Nucleotide; Tyrosine | 2008 |